Navigating peptide procurement for preclinical research requires absolute analytical clarity and verifiable purity. Glycyl-L-histidyl-L-lysine copper (GHK-Cu) is a widely investigated copper-binding tripeptide known for modulating extracellular matrix synthesis and gene expression in vitro. PX1 Research provides high-grade GHK-Cu accompanied by comprehensive lot-specific Certificates of Analysis (COA) to ensure experimental reproducibility across laboratory workflows.
Navigating peptide procurement for preclinical research requires absolute analytical clarity and verifiable purity. Glycyl-L-histidyl-L-lysine copper (GHK-Cu) is a widely investigated copper-binding tripeptide known for modulating extracellular matrix synthesis and gene expression in vitro. PX1 Research provides high-grade GHK-Cu accompanied by comprehensive lot-specific Certificates of Analysis (COA) to ensure experimental reproducibility across laboratory workflows.
A verifiable Certificate of Analysis (COA) for a GHK-Cu peptide (glycyl-L-histidyl-L-lysine copper complex) confirms its identity, chemical purity, and safety profile for laboratory research. Standard COAs for analytical-grade GHK-Cu must include Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms establishing purity (typically ≥98%), Liquid Chromatography-Mass Spectrometry (LC-MS) confirming molecular weight (approx. 404.5 g/mol for the free base complex), and chromogenic LAL assays quantifying bacterial endotoxin levels.
When acquiring GHK-Cu for in vitro or animal models, researchers must insist on lot-specific documentation generated by independent ISO 17025-accredited testing facilities. This verification ensures that structural chelation, amino acid sequence integrity, and counter-ion content meet strict quantitative thresholds, avoiding confounding variables in cell culture assays or tissue remodeling assays.
GHK-Cu is a naturally occurring tripeptide complex first isolated from human plasma that exhibits an unusually high affinity for copper divalent ions (Cu2+). The molecular sequence—Gly-His-Lys—forms a stable coordination complex where the histidine residue imidazole ring, the nitrogen from the glycine terminal amino group, and the amide nitrogens participate in chelating the Cu2+ ion. This spatial configuration enables GHK-Cu to function as a bio-available copper carrier, shuttling essential trace elements directly to cellular receptors and enzymatic systems.
In physiological and experimental systems, copper is a critical cofactor for enzymes such as lysyl oxidase (LOX), superoxide dismutase (SOD1/SOD3), and cytochrome c oxidase. By delivering copper directly to these enzymatic pathways, GHK-Cu influences matrix crosslinking, oxidative stress neutralization, and cellular bioenergetics. Researchers exploring research peptides often examine GHK-Cu specifically for its unique dual identity: acting simultaneously as a signal peptide capable of downregulating inflammatory cytokines and as a carrier peptide facilitating enzymatic activation.
In vitro and animal models consistently demonstrate that GHK-Cu acts as a potent regulator of extracellular matrix (ECM) biosynthesis. Preclinical studies suggest that GHK-Cu stimulates mRNA expression and protein secretion of type I and type III collagen in cultured dermal fibroblasts. Additionally, research indicates a marked upregulation of elastin synthesis, decorin, and glycosaminoglycans (GAGs), which together form the structural framework of healthy connective tissue.
Unlike non-specific proliferative agents, GHK-Cu appears to promote balanced matrix remodeling rather than unchecked fibrotic deposition. In cell culture models, the tripeptide modulates the activity of matrix metalloproteinases (MMPs)—specifically MMP-1 and MMP-2—alongside their endogenous inhibitors, TIMP-1 and TIMP-2. This dual regulation ensures controlled turnover of damaged extracellular proteins while facilitating the deposition of organized, newly synthesized matrix proteins. Laboratories investigating structural proteins frequently utilize our research library to evaluate how GHK-Cu compares with other remodeling peptides in standardized fibroblast cultures.
Wound healing assays in rodent models have highlighted GHK-Cu's capacity to accelerate re-epithelialization and tissue repair. In vivo data indicate that topical or localized application of GHK-Cu enhances macrophage chemoattraction, stimulates neo-vascularization through vascular endothelial growth factor (VEGF) pathway modulation, and increases local nerve growth factor (NGF) expression. These combined mechanisms support rapid cell migration across denuded tissue boundaries.
Crucially, preclinical evidence reveals that GHK-Cu exhibits anti-fibrotic characteristics during late-stage tissue repair. In models of hypertrophic scarring and fibrotic organ injury, GHK-Cu has been observed to suppress transforming growth factor-beta 1 (TGF-β1) signaling while upregulating anti-fibrotic factors such as decorin. This pathway modulation shifts the healing response away from dense, misaligned collagen scarring toward normalized, functional tissue architecture. Researchers focused on tissue integrity often explore these pathways within specialized models detailed in our analysis of wound healing mechanisms.
When designing comparative preclinical trials, investigators frequently evaluate GHK-Cu alongside other signal peptides and tissue regeneration compounds to elucidate distinct mechanism-of-action profiles.
For instance, while GHK-Cu primarily targets copper delivery, ECM turnover, and gene expression modulation in fibroblasts, BPC-157 acts largely through VEGFR2 activation and nitric oxide pathway regulation to promote angiogenesis and soft tissue repair. Similarly, TB-500 functions via actin sequestration and cell migration pathways, accelerating endothelial and myoblast cell motility without direct trace-metal chelation. In cosmetic and dermatological peptide screening, investigators may also compare GHK-Cu with synthetic matrix signaling analogs like palmitoyl tripeptide-1, evaluating differences in cellular uptake, receptor affinity, and stability in cell culture media. Understanding these biochemical distinctions allows laboratories to select the precise peptide or combination necessary for their target assay.
A Certificate of Analysis is not simply a compliance sheet; it is the ultimate quantitative proof of a chemical compound's suitability for controlled experimentation. When reviewing a COA for GHK-Cu, researchers must verify several key analytical parameters before introducing the material to cell culture or animal assays.
The primary metrics to evaluate include analytical purity percentage, mass confirmation, peptide content, residual solvent analysis, and heavy metal limits. A compliant COA must explicitly link the batch number on the vial directly to the raw data files produced by the testing equipment. Laboratories ordering through our wholesale lab account portal receive batch-matched, downloadable COAs generated by certified third-party testing laboratories for full operational transparency.
To guarantee high fidelity in preclinical data, PX1 Research subjects every batch of GHK-Cu to a rigorous three-tier analytical pipeline within an ISO 17025-accredited laboratory environment:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): RP-HPLC separates the primary GHK-Cu peptide from synthesis side-products, truncated sequences, or unchelated precursors. Peak area integration at specific UV wavelengths (typically 214 nm and 280 nm) calculates the precise purity percentage. Standard research grade requires a minimum purity of 98.0%. 2. Liquid Chromatography-Mass Spectrometry (LC-MS): While HPLC measures purity, MS confirms molecular identity. LC-MS records the mass-to-charge ratio (m/z) of the peptide ion, verifying that the observed molecular weight corresponds exactly to the theoretical molecular mass of the GHK copper complex. 3. Chromogenic Kinetic LAL Endotoxin Testing: Bacterial endotoxins (lipopolysaccharides) alter cell culture viability and induce non-specific immune responses in animal models. Our testing protocols measure endotoxin content using Limulus Amebocyte Lysate assays, ensuring levels remain well below standard preclinical thresholds (<0.5 EU/mg).
The table below outlines the rigorous chemical and analytical standards met by PX1 Research GHK-Cu lots prior to release:
• Chemical Formula: C14H24CuN6O4 (free base complex) • Molecular Mass: ~403.93 g/mol (free base) / ~404.5 g/mol (standard ion complex) • Sequence: H-Gly-His-Lys-OH · Cu2+ · xHOAc • Purity Grade: ≥98.0% (determined by RP-HPLC) • Mass Identification: Conforms to molecular structure via LC-MS • Appearance: Lyophilized blue powder (characteristic of copper chelation) • Endotoxin Limit: <0.1 to <0.5 EU/mg (batch validated) • Manufacturing Origin: Synthesized in USA-based, GMP-compliant facilities
Proper handling of GHK-Cu in a laboratory setting is critical to maintaining peptide stability and preventing enzymatic degradation or premature metal dissociation. Lyophilized GHK-Cu powder is stable at room temperature for brief periods during transit, but long-term storage requires temperature control. Upon receipt, unopened vials should be stored at -20°C or -80°C in a desiccated environment protected from light.
For reconstitution, researchers should use sterile Bacteriostatic Water, Sterile Water for Injection, or phosphate-buffered saline (PBS), depending on the requirements of the downstream assay. Gently swirl the vial until the blue powder completely dissolves; avoid violent vortexing or sonication, which can cause mechanical shear stress. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at -20°C for up to several months, or at 2°C to 8°C for short-term use (up to 30 days). For detailed storage protocols, refer to our comprehensive guide on extracellular matrix peptides.
For research institutions, contract research organizations (CROs), and academic laboratories, supplier integrity directly dictates data validity. PX1 Research manufactures all research peptides in modern USA-based facilities adhering to strict Good Manufacturing Practice (GMP) principles. We eliminate supply-chain ambiguity by providing transparent, lot-traceable documentation for every compound cataloged.
Orders placed before standard daily cutoffs ship same-day from our fulfillment hubs located in California and Arizona. Each shipment includes secure packaging designed to preserve peptide integrity during transport. By pairing rigid analytical standards—such as ISO 17025 third-party verification, RP-HPLC purity, LC-MS mass confirmation, and LAL endotoxin testing—with rapid shipping, PX1 Research serves as a dependable primary partner for advanced preclinical workflows.
What information should be listed on a GHK-Cu Certificate of Analysis (COA)?
A standard research COA for GHK-Cu must state the compound name, batch/lot number, manufacturer details, sequence, theoretical vs. observed molecular weight (via LC-MS), numerical purity percentage (via RP-HPLC), endotoxin test results (in EU/mg), physical appearance, and date of analytical testing.
Why is GHK-Cu lyophilized powder blue?
GHK-Cu is an active copper-chelated complex. Divalent copper ions (Cu2+) bound to the Gly-His-Lys tripeptide absorb light in the red spectrum, giving the purified lyophilized powder its characteristic bright blue color.
What HPLC purity level is required for cell culture research on GHK-Cu?
For reliable cell culture and in vitro signaling assays, researchers should select GHK-Cu with a verified RP-HPLC purity of ≥98.0%. Lower purity grades may introduce unchelated peptide fragments, free copper ions, or synthesis impurities that confound cellular responses.
How does PX1 Research verify endotoxin levels in GHK-Cu lots?
PX1 Research utilizes chromogenic Limulus Amebocyte Lysate (LAL) assays conducted by independent ISO 17025 laboratories to quantify bacterial endotoxin levels. All qualified lots must fall below stringent preclinical limits (typically <0.5 EU/mg).
What solvent should be used for reconstituting GHK-Cu in laboratory experiments?
GHK-Cu is highly water-soluble. Reconstitution can be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or sterile phosphate-buffered saline (PBS, pH 7.4), depending on assay sensitivity and environmental requirements.
What is the recommended storage temperature for GHK-Cu powder?
Lyophilized GHK-Cu powder should be stored at -20°C for long-term stability (up to 2 years) or -80°C for extended archival storage. Unopened vials should be kept away from ambient moisture and direct light exposure.
Can reconstituted GHK-Cu undergo multiple freeze-thaw cycles?
Repeated freeze-thaw cycles can cause physical degradation of the peptide sequence and alter copper binding. Researchers are advised to aliquot reconstituted stock solutions into single-use volumes before freezing.
How does GHK-Cu compare to BPC-157 in tissue repair models?
GHK-Cu functions primarily by regulating extracellular matrix remodeling, collagen/elastin expression, and copper-dependent enzymatic pathways. In contrast, BPC-157 acts predominantly through endothelial nitric oxide modulation, VEGFR2 pathways, and anti-inflammatory signaling. Both are frequently studied in comparative soft-tissue repair protocols.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.